通过DNA-PKcs激酶活性对基因表达的基底和以太化物诱导的变化的比较分析
Sk Imran Ali1, Mohammad J Najaf-Panah1, Kennedi B Pyper1
1Department of Chemistry and Biochemistry, New Mexico State University, Las Cruces, NM, United States.
Frontiers in genetics
|April 5, 2024
概括
DNA-PKcs 激酶活性抑制了DNA损伤后的炎症. 基因酶不活性DNA-PKcs导致炎症反应增加,影响癌症治疗策略.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 基因组维护对细胞生存至关重要;DNA损伤反应缺陷与癌症和神经系统疾病有关.
- DNA-蛋白激酶催化子单元 (DNA-PKcs) 对于DNA修复和基因表达调节至关重要.
- 它在调节细胞对DNA损伤反应中的作用至关重要.
研究的目的:
- 为了研究野生类型 (WT) 与激酶不活性 (KR) DNA-PKcs.的细胞中的全球基因表达变化.
- 了解在DNA-PKcs激酶活性存在或不存在的情况下对DNA损伤的转录反应.
- 为了确定受DNA-PKcs状态影响的关键转录调节者.
主要方法:
- 全球基因表达分析使用在WT和KRDNA-PKcs细胞上的RNA测序.
- 评估未经处理的细胞和以太胺诱导的DNA损伤后的转录变化.
- 途径分析以确定主转录调节剂和qPCR进行验证.
主要成果:
- 基因酶不活性DNA-PKcs细胞显示出不同的基因表达特征,特别是与WT细胞相比,炎症反应加剧.
- 下调基因主要参与两种基因型的生物合成途径.
- 途径分析揭示了对组织素修饰,炎症,细胞循环,Wnt/β-catenin信号传递和细胞发育的调节者的显著影响.
结论:
- DNA-PKcs 激酶活性对于抑制基因毒性压力后的促炎信号是必不可少的.
- 了解抑制DNA-PKcs激酶活性的转录后果对于优化结合DNA破坏剂和DNA-PK抑制剂的癌症疗法至关重要.
更多相关视频
09:39Author Spotlight: Combining Proximity Ligand Assay with Gamma-H2AX Staining to Characterize Protein Interactions in DNA Damage Response
Published on: August 2, 2024
479
10:12Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
2.8K
相关概念视频
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
